<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In order to investigate the significance of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and proliferation rates in differential diagnosis, evaluating curative effect and <z:hpo ids='HP_0001909'>leukemia</z:hpo> transformation in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, <z:mpath ids='MPATH_3'>apoptosis</z:mpath> index (AI) and proliferating index (PI) were assayed in marrow smears from 60 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, 30 AML, 21 <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (CAA), 16 <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo>, 15 <z:hpo ids='HP_0001889'>megaloblastic anemia</z:hpo> and 30 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="1" pm="."><plain>The apoptotic cells were assayed with TUNEL technique and proliferating cell nuclear antigen (PCNA) by immunohistochemical method in situ </plain></SENT>
<SENT sid="2" pm="."><plain>The results showed that average AI in marrow smears from 39 cases with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> prior therapy was (11.2 +/- 8.8)% and PI was (17.3 +/- 8.7)%, significant differences were observed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> group and <z:mpath ids='MPATH_458'>normal</z:mpath> control group, as well as in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, CAA, <z:hpo ids='HP_0001889'>megaloblastic anemia</z:hpo> and <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo> groups </plain></SENT>
<SENT sid="3" pm="."><plain>Hypoplastic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> can be distinguished from CAA by AI and PI </plain></SENT>
<SENT sid="4" pm="."><plain>Clinical therapy induced significant alteration of AI and PI in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and CAA </plain></SENT>
<SENT sid="5" pm="."><plain>After therapy of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, the AI dropped from (11.2 +/- 8.8)% to (6.6 +/- 0.7)% </plain></SENT>
<SENT sid="6" pm="."><plain>It was concluded that examination of AI and PI of marrow cells in situ may provide valuable prognostic information, also can contribute to evaluate therapeutic effectiveness </plain></SENT>
</text></document>